ELV
Elevance Health, Inc.
HOSPITAL & MEDICAL SERVICE PLANS
Elevance Health (ELV) Stock: Buy, Sell, or Hold?
$429.65
+11.40 (+2.73%)
▲
5d:
+3.84%
30d:
+1.79%
90d:
+7.64%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 21, 2026
0d
Protect ELV Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (64%)
Quality Score
54/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$399.08 – $434.13
Position: SLIGHTLY HIGH
Forward P/E & Valuation
14.2x
FAIR
vs 12.8x historical avg
Wall Street Target
$482.38
+12.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$406.90 / $448.54
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: ELV is fairly valued with market pricing in 3.6% annual growth. Fine to hold or accumulate slowly on dips.
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$470.51
Based on 4.0% avg growth
INTRINSIC VALUE TODAY
$292.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $429.65, which is considered slightly high relative to its 30-day fair value range of $399.08 to $434.13. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.2) compared to its historical average (12.8). At these levels, the market is pricing in 3.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ELV is in a uptrend. Immediate support is located at $406.90, while resistance sits at $448.54.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $482.38 (+12.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ELV is in a uptrend. Immediate support is located at $406.90, while resistance sits at $448.54.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $482.38 (+12.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$399.08 -
$434.13
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.8%
Trading Range & Key Levels
30-Day Trading Range
$399.08 -
$434.13
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$406.90
Resistance Level
$448.54
Current Trend
Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding ELV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($482.38)
- NEUTRAL: Market pricing in 3.6% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (45/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
14.19
Wall Street Target
$482.38
(+12.3%)
Revenue Growth (YoY)
1.4%
Earnings Growth (YoY)
17.9%
Profit Margin
2.5%
Valuation Premium vs History
+3.6% premium
PE vs Historical
14.2 vs 12.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$445.12
(+4%)
2-Year Target
$461.14
(+7%)
3-Year Target
$477.74
(+11%)
3-Yr Target (if PE normalizes)
(PE: 14→13)
PE COMPRESSION
$431.05
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 3.9%)
$675.41
(+57%)
Base:
(SPY PE: 14.2, Growth: 3.9%)
$482.46
(+12%)
Bear:
(PE: 12.1, Growth: 3.9%)
$410.09
(-5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 17.76 | Current EPS (TTM): $23.55
Bull Case
$591.67
(+38%)
Analyst growth 28.6%, PE expands to 19.5
Base Case
$537.88
(+25%)
Market implied 28.6%, PE stable at 17.8
Bear Case
$284.41
(-34%)
Severe decline -20.0%, PE contracts to 15.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share ELV Analysis
Share this live ELV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ELV)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
An $11 billion fund, ACR Alpine Capital Research, has significantly increased its position in Elevance Health (ELV), making it one of the fund's top 10 holdings. Elevance Health raised its earnings forecast for 2026, and ACR's investment could indicate a bullish outlook.
Key Retail Themes:
Fund Positioning
Earnings Growth
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:16 AM ET
Data refreshes hourly during market hours. Next update: 9:16 AM
Data refreshes hourly during market hours. Next update: 9:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
27 analysts |
$115 | 50 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
26 analysts |
$477 | 53 HOLD |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 64 BUY |
|
CI
The Cigna Group |
STRONG BUY
24 analysts |
$342 | 51 HOLD |
|
ALHC
Alignment Healthcare LLC |
BUY
15 analysts |
$11 | 51 HOLD |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ELV Research Pages
